Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
65 hedge funds and large institutions have $797M invested in Repare Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 14 closing their positions.
92% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 13
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
3% more funds holding
Funds holding: 63 → 65 (+2)
2.51% more ownership
Funds ownership: 67.93% → 70.44% (+2.5%)
7% less capital invested
Capital invested by funds: $858M → $797M (-$61M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$25.5M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$24.6M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$7.58M |
| 4 |
JP Morgan Chase
New York
|
+$6.27M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$13.8M |
| 2 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$13.6M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$10.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.88M |
| 5 |
Millennium Management
New York
|
-$3.26M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
State Street
Boston,
Massachusetts
| – | -$207K | -6,035 | Closed |
|
|
BCV
77
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | -$103K | -3,000 | Closed |
|
|
IA
78
IFP Advisors
Tampa,
Florida
| – | -$6.79K | -200 | Closed |
|
RPTX Hedge Fund Activity: Q1 2021 in Review
65 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q1 2021, worth a combined $797M — down 7.1% from $858M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new RPTX positions and 14 closed out — a net gain of 2 holders — while 25 added to existing stakes and 13 trimmed.
The largest buyer was BVF Inc, adding an estimated $25.5M. The largest seller was Franklin Resources, cutting an estimated $13.8M.
- 65 institutional investors held Repare Therapeutics (RPTX) as of Q1 2021, up from 63 in Q4 2020.
- Funds reported $797M of Repare Therapeutics stock for Q1 2021, down 7.1% quarter-over-quarter.
- 16 funds opened new Repare Therapeutics positions in Q1 2021 and 14 closed out, a net change of +2 holders.
- The largest Repare Therapeutics buyer in Q1 2021 was BVF Inc, an estimated $25.5M added.
- The largest Repare Therapeutics seller in Q1 2021 was Franklin Resources, an estimated $13.8M sold.
Based on aggregated 13F filings for Q1 2021.